Drugs / AlloGen-LI
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02932020 | Oct 2016 → Sep 2017 | — | University of Southern California | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AlloGen-LI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02932020 ↗ |
| Modality | Other / unclassified | “an allograft derived from amniotic fluid” NCT02932020 ↗ |
| Route | Other | “injected into the epidural space” NCT02932020 ↗ |